227. Osler disease
49 clinical trials,   69 drugs   (DrugBank: 21 drugs),   23 drug target genes,   132 drug target pathways

Searched query = "Osler disease", "Hereditary hemorrhagic telangiectasia", "Osler-Weber-Rendu disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03850730
(ClinicalTrials.gov)
September 201912/2/2019Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic TelangiectasiaAn Open-label, Non-randomized Study of the Efficacy of Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)Hereditary Hemorrhagic Telangiectasia;EpistaxisDrug: PazopanibCure HHTUniversity of North CarolinaNot yet recruiting18 Years75 YearsAll30Phase 1;Phase 2NULL
2NCT03850964
(ClinicalTrials.gov)
September 201912/2/2019Pazopanib Effects on Bleeding in Hereditary Hemorrhagic TelangiectasiaRandomized Double Blind Study to Evaluate the Effect of Low Dose Pazopanib on Bleeding Due to Hereditary Hemorrhagic TelangiectasiaHereditary Hemorrhagic Telangiectasia;Epistaxis Nosebleed;AnemiaDrug: Pazopanib;Drug: Placebo oral capsuleCure HHTNULLNot yet recruiting18 Years75 YearsAll45Phase 2;Phase 3NULL